Molecular Docking facilitates the identification of potential drug candidates by predicting their binding affinity and interaction patterns with specific targets, such as androgen receptors, insulin receptors, or inflammatory mediators involved in PCOS. This evidence concerns the gene AR and polycystic ovary syndrome.